Advocacy & Public Policy
Resources from the 黑料正能量 Association (AHA) on advocacy and public policy health care issues.
The Food and Drug Administration yesterday issued a warning letter to CanaRx, a company that contracts with employers to provide select prescription drugs to employees, for facilitating the distribution of unapproved and misbranded drugs.
Tom Nickels
Executive Vice President
黑料正能量 Association
AHA urges the Senate to co-sponsor the Resident Physician Shortage Reduction Act of 2019
(S. 348), a bipartisan bill, authored by Senators Menendez, Boozman and Schumer, that would
increase the number of Medicare-funded residency positions by 15,000 over five years,
thereby helping to alleviate鈥
Congress last night approved legislation providing discretionary funding for certain federal programs for fiscal year 2019, preventing a shutdown of those programs tonight when their current funding expires.
Earlier this month AHA released a blog post that pointed out numerous flaws in a recent Health Affairs study on hospital and physician prices between 2007 and 2014. We asked the respected economics consulting firm Charles River Associates to take an even closer at why the study鈥檚 findings are鈥
Every day, hospitals and health systems see the value that information exchange has on care improvement and patient engagement. Today, nearly all hospitals and health systems enable patients to view information from their health record online, and each year brings additional gains in sharing across鈥
AHA letter to Senator Robert Menendez expressing support for the Resident Physician Shortage Reduction Act, legislation that would add 15,000 Medicare-funded residency positions over five years to alleviate physician shortages that threaten patients' access to care.
The authors of this Health Affairs study on hospital and physician prices use limited data to draw broad conclusions.
The Senate Finance Committee today held the first in a planned series of bipartisan hearings on high prescription drug prices and potential policy and oversight solutions to lower costs for patients.